Author:
Blauvelt Andrew,Reich Kristian,Tsai Tsen-Fang,Tyring Stephen,Vanaclocha Francisco,Kingo Külli,Ziv Michael,Pinter Andreas,Vender Ronald,Hugot Sophie,You Ruquan,Milutinovic Marina,Thaçi Diamant
Reference28 articles.
1. Secukinumab in plaque psoriasis: results of two phase 3 trials;Langley;N Engl J Med,2014
2. Secukinumab administration by pre-filled syringe: efficacy, safety, and usability results from a randomized controlled trial in psoriasis (FEATURE);Blauvelt;Br J Dermatol,2015
3. Efficacy, safety, and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE);Paul;J Eur Acad Dermatol Venereol,2015
4. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis;Mease;N Engl J Med,2015
5. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial;McInnes;Lancet,2015
Cited by
270 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献